Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124797648 | 12479764 | 8 | F | 20160705 | 20160825 | 20160620 | 20160905 | EXP | US-PFIZER INC-2016285752 | PFIZER | 79.00 | YR | F | Y | 88.00000 | KG | 20160905 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124797648 | 12479764 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, UNK (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 124797648 | 12479764 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 124797648 | 12479764 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 124797648 | 12479764 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 124797648 | 12479764 | 5 | C | METOPROLOL. | METOPROLOL | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 8 | C | VITAMIN B | VITAMIN B | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 10 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 11 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 12 | C | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 13 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 14 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 15 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124797648 | 12479764 | 16 | C | PREVALITE | CHOLESTYRAMINE | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124797648 | 12479764 | 1 | Metastatic renal cell carcinoma |
| 124797648 | 12479764 | 12 | Crohn's disease |
| 124797648 | 12479764 | 16 | Abnormal faeces |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124797648 | 12479764 | OT |
| 124797648 | 12479764 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124797648 | 12479764 | Arthralgia | |
| 124797648 | 12479764 | Asthenia | |
| 124797648 | 12479764 | Blister | |
| 124797648 | 12479764 | Blood pressure decreased | |
| 124797648 | 12479764 | Conjunctivitis | |
| 124797648 | 12479764 | Constipation | |
| 124797648 | 12479764 | Decreased appetite | |
| 124797648 | 12479764 | Diarrhoea | |
| 124797648 | 12479764 | Dry mouth | |
| 124797648 | 12479764 | Dry skin | |
| 124797648 | 12479764 | Dysgeusia | |
| 124797648 | 12479764 | Dyspepsia | |
| 124797648 | 12479764 | Eye discharge | |
| 124797648 | 12479764 | Faeces soft | |
| 124797648 | 12479764 | Fatigue | |
| 124797648 | 12479764 | Gastrointestinal haemorrhage | |
| 124797648 | 12479764 | Haemorrhoids | |
| 124797648 | 12479764 | Hypersensitivity | |
| 124797648 | 12479764 | Hypertension | |
| 124797648 | 12479764 | Incontinence | |
| 124797648 | 12479764 | Kidney infection | |
| 124797648 | 12479764 | Malaise | |
| 124797648 | 12479764 | Memory impairment | |
| 124797648 | 12479764 | Ocular hyperaemia | |
| 124797648 | 12479764 | Pain in extremity | |
| 124797648 | 12479764 | Peripheral swelling | |
| 124797648 | 12479764 | Pruritus | |
| 124797648 | 12479764 | Sinus disorder | |
| 124797648 | 12479764 | Sleep disorder | |
| 124797648 | 12479764 | Urinary tract infection | |
| 124797648 | 12479764 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124797648 | 12479764 | 1 | 20160519 | 20160630 | 0 | |
| 124797648 | 12479764 | 2 | 20160711 | 20160713 | 0 | |
| 124797648 | 12479764 | 3 | 20160718 | 20160807 | 0 | |
| 124797648 | 12479764 | 4 | 20160817 | 0 | ||
| 124797648 | 12479764 | 13 | 20160616 | 0 | ||
| 124797648 | 12479764 | 14 | 20160616 | 0 | ||
| 124797648 | 12479764 | 15 | 20160615 | 0 |